ss 1–2 comm on date of assent

pts 1 (other than ss 1–2), 2 (other than s 14), 9 (other than ss 147(1)(a)–(c), (f), 150(3)(a), (4), div 5), pts 11 (other than s 199(a)(i), (vii), (d)), 12, 13 (other than ss 207–209), sch 1 (other than defs authorised pharmacist, chief executive officer, inspector, licensed pharmacy business, licensed premises, pharmacy business licence) comm 1 September 2024 (2024 SL No. 193)

pt 9 div 5, pt 14 (other than s 213 defs deemed eligible person, existing pharmacy business, repealed, repealed Act, divs 2, 4), pt 15 (other than divs 1–2, 4), sch 1 def chief executive officer comm 16 June 2025 (2025 SL No. 29)

s 14, pts 3–8, ss 147(1)(a)–(c), (f), 150(3)(a), (4), pt 10, ss 199(a)(i), (vii), (d), 207–209, 213 defs deemed eligible person, existing pharmacy business, repealed, repealed Act, pt 14 divs 2, 4, pt 15 divs 1–2, 4, sch 1 defs authorised pharmacist, inspector, licensed pharmacy business, licensed premises, pharmacy business licence not yet proclaimed into force (automatic commencement under AIA s 15DA(2) postponed to 29 March 2026 (2024 SL No. 194))